Thursday, April 19, 2018
Pharma Advancement
  • Home
  • News

    CPhI & P-MEC China 2018: Build lucrative pharma business partnerships in China

    More Than 60% of Drug Safety Experts Plan To Use AI to Improve the Speed and Security of Adverse Event Case Processing

    Sanofi, Novonordisk and Novartis Iran are 2018’s Best Places to Work in Iran

    Sanofi, Novonordisk and Novartis Iran are 2018’s Best Places to Work in Iran

    Chemspec Europe 2018:Introduction of Partnering Programme adds new level of networking

    EMA Advises Recall of AbbVie, Biogen MS Drug

    EMA Advises Recall of AbbVie, Biogen MS Drug

    Novartis’ take on what to expect as tech transforms healthcare

    Pfizer encourages public to view and listen webcast of its presentation at Healthcare conference

    Pfizer encourages public to view and listen webcast of its presentation at Healthcare conference

    Merck and Eisai collaborate to develop and sell Eisai cancer drug

    Shire announce its Pivotal study for Hereditary Angioedema at 2018 AAAAI/WAO Joint Congress

  • Market Moves
    Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

    Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

    Alexon pharmaceuticals brings updates on its FY18 Earnings Guidance

    FDA Approves Avycaz for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

    Ablynx Enters €3.9bn Acquisition Deal With Sanofi

    Top Employer”2018- Sanofi

    Sanofi initiates Tender Offer for purchasing Bioverativ Inc

    Roche secure shares in tender offer for Ignyta, Inc

    Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

    Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

    Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris

    Agilent Expands Cell Analysis Portfolio with Acquisition of Luxcel Biosciences

  • Press Statements
  • White Papers
  • Events & Exhibitions
  • Contact Us
No Result
View All Result
  • Home
  • News

    CPhI & P-MEC China 2018: Build lucrative pharma business partnerships in China

    More Than 60% of Drug Safety Experts Plan To Use AI to Improve the Speed and Security of Adverse Event Case Processing

    Sanofi, Novonordisk and Novartis Iran are 2018’s Best Places to Work in Iran

    Sanofi, Novonordisk and Novartis Iran are 2018’s Best Places to Work in Iran

    Chemspec Europe 2018:Introduction of Partnering Programme adds new level of networking

    EMA Advises Recall of AbbVie, Biogen MS Drug

    EMA Advises Recall of AbbVie, Biogen MS Drug

    Novartis’ take on what to expect as tech transforms healthcare

    Pfizer encourages public to view and listen webcast of its presentation at Healthcare conference

    Pfizer encourages public to view and listen webcast of its presentation at Healthcare conference

    Merck and Eisai collaborate to develop and sell Eisai cancer drug

    Shire announce its Pivotal study for Hereditary Angioedema at 2018 AAAAI/WAO Joint Congress

  • Market Moves
    Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

    Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

    Alexon pharmaceuticals brings updates on its FY18 Earnings Guidance

    FDA Approves Avycaz for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

    Ablynx Enters €3.9bn Acquisition Deal With Sanofi

    Top Employer”2018- Sanofi

    Sanofi initiates Tender Offer for purchasing Bioverativ Inc

    Roche secure shares in tender offer for Ignyta, Inc

    Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

    Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

    Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris

    Agilent Expands Cell Analysis Portfolio with Acquisition of Luxcel Biosciences

  • Press Statements
  • White Papers
  • Events & Exhibitions
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Market Moves

SQI Diagnostics Completes Sale of Automated Sqidlite Platform to Predictive Cardiac Customer

arbind by arbind
30th November 2017
in Market Moves
SQI Diagnostics Completes Sale of Automated Sqidlite Platform to Predictive Cardiac Customer

SQI Diagnostics Inc. announced it has successfully converted a multi-biomarker cardiac event prediction test from a pioneer in the field of predictive diagnostic medicine, into an SQI-based multiplex test. The test has also been successfully automated on SQI’s “sample-to-answer” sqidlite™ system.

SQI is a life sciences and diagnostics company that develops and commercializes proprietary multiplexing technologies and products for advanced microarray diagnostics.

Based on the successful completion of product development and test automation by SQI, the customer has acquired a sqidlite for their CLIA laboratory in Irvine, California. This sqidlite system will be installed and undergo final validation in this customer’s CLIA laboratory in December 2017 where they are already servicing thousands of patients from North America annually. The predictive cardiac tests will also be available to their global customer base of renowned cardiologists, hospitals, and reference laboratories around the world.

“We are pleased to be advancing the relationship with this innovative cardiac testing pioneer to the commercial stage,” said Andrew Morris, CEO of SQI Diagnostics. “We believe the revenue potential for kits sales of this product is very promising and we look forward to working with this world-class predictive health innovator to service their large and growing list of customers using this important predictive diagnostic tool in their clinics.”

About SQI Diagnostics
SQI Diagnostics is the life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The Company’s proprietary microarray tests and fully-automated systems are designed to simplify protein and antibody testing workflow, increase throughput, reduce costs and provide excellent data quality.
For more information, please visit www.sqidiagnostics.com

Sales and Marketing Contact:
Vice President,
Global Commercial Operations
Russ Peloquin
913.484.9022
rpeloquin@sqidiagnostics.com

SQI Investor Relations Contact:
Chief Executive Officer
Andrew Morris
416.674.9500 ext. 229
amorris@sqidiagnostics.com

Vice President,
Finance and Administration
Patricia Lie
416.674.9500 ext. 277
plie@sqidiagnostics.com

Previous Post

Merck Opens Production Facility for Liquid Crystal Window Modules

Next Post

Pfizer Enters Into Agreement To Develop And Commercialize Cresemba® (Isavuconazole) In China And Asia Pacific Region

Related Posts

Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy
Market Moves

Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

22nd March 2018
Market Moves

Alexon pharmaceuticals brings updates on its FY18 Earnings Guidance

5th March 2018
Featured

FDA Approves Avycaz for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

10th February 2018
Featured

Ablynx Enters €3.9bn Acquisition Deal With Sanofi

10th February 2018
Top Employer”2018- Sanofi
Market Moves

Sanofi initiates Tender Offer for purchasing Bioverativ Inc

9th February 2018
Market Moves

Roche secure shares in tender offer for Ignyta, Inc

9th February 2018
Next Post

Pfizer Enters Into Agreement To Develop And Commercialize Cresemba® (Isavuconazole) In China And Asia Pacific Region

Latest News

Clinical Trials

BERG Announces the Dosing of First UK Patient in Phase II Combination Trial of BPM 31510 and Gemcitabine for Patients with Pancreatic Cancer

6th April 2018
Asia

CPhI & P-MEC China 2018: Build lucrative pharma business partnerships in China

3rd April 2018
Americas

More Than 60% of Drug Safety Experts Plan To Use AI to Improve the Speed and Security of Adverse Event Case Processing

23rd March 2018
Press Statements

Prothena Announces Global Neuroscience R&D Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases

23rd March 2018
Clinical Trials

Roche’s TECENTRIQ plus chemotherapy reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced squamous lung cancer: Phase III IMpower131 study

23rd March 2018
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • News
  • Market Moves
  • Press Statements
  • White Papers
  • Events & Conferences

Resources

  • Advertise with us
  • Contact Us

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Download Media Pack

Close

x
No Result
View All Result
  • Home
  • News
  • Market Moves
  • Press Statements
  • White Papers
  • Events & Exhibitions
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In